Barclays
OPTR

Barclays’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Barclays’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-50,000
Closed -$724K – 7876
2013
Q2 		$724K Buy
+50,000
New +$728K ﹤0.01% 3778

Barclays's OPTR Position: Q4 2013 in Review

Barclays sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 2,625 shares — an estimated $32K sold.

Barclays first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $597K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Barclays reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Barclays sold 2,625 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $32K.
  • Barclays first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Barclays's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $597K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.